Senestech, Inc. (NASDAQ:SNES) Sees Significant Decrease in Short Interest

Senestech, Inc. (NASDAQ:SNESGet Free Report) was the target of a large decrease in short interest in the month of July. As of July 15th, there was short interest totaling 27,608 shares, a decrease of 49.7% from the June 30th total of 54,875 shares. Currently, 0.5% of the company’s shares are short sold. Based on an average daily volume of 64,738 shares, the days-to-cover ratio is presently 0.4 days.

Senestech Stock Down 5.2%

Shares of Senestech stock traded down $0.07 during trading on Wednesday, reaching $1.27. 28,712 shares of the company traded hands, compared to its average volume of 61,252. The company has a debt-to-equity ratio of 0.02, a current ratio of 8.91 and a quick ratio of 7.79. Senestech has a 1-year low of $1.26 and a 1-year high of $6.24. The company has a 50 day moving average price of $1.56 and a 200-day moving average price of $1.76. The firm has a market capitalization of $6.73 million, a PE ratio of -0.67 and a beta of 0.28.

Senestech (NASDAQ:SNESGet Free Report) last issued its earnings results on Tuesday, May 12th. The company reported ($0.31) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.33) by $0.02. Senestech had a negative net margin of 304.22% and a negative return on equity of 67.60%. The business had revenue of $0.49 million for the quarter, compared to analyst estimates of $0.63 million. As a group, equities research analysts expect that Senestech will post -1.57 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Weiss Ratings upgraded Senestech from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, July 10th. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Senestech currently has a consensus rating of “Hold”.

Get Our Latest Stock Report on SNES

Insiders Place Their Bets

In other news, major shareholder Glenbrook Capital Management purchased 35,000 shares of the stock in a transaction on Monday, July 20th. The stock was purchased at an average price of $1.47 per share, for a total transaction of $51,450.00. Following the acquisition, the insider owned 1,057,824 shares in the company, valued at $1,555,001.28. This trade represents a 3.42% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Over the last three months, insiders have purchased 143,773 shares of company stock worth $224,802. Corporate insiders own 2.20% of the company’s stock.

Institutional Trading of Senestech

Several large investors have recently made changes to their positions in SNES. Geode Capital Management LLC acquired a new position in Senestech during the 2nd quarter worth approximately $59,000. Jane Street Group LLC acquired a new stake in Senestech in the fourth quarter valued at approximately $32,000. Diversify Advisory Services LLC acquired a new stake in Senestech in the fourth quarter valued at approximately $34,000. Diversify Wealth Management LLC bought a new stake in shares of Senestech during the first quarter valued at approximately $31,000. Finally, XTX Topco Ltd bought a new stake in shares of Senestech during the fourth quarter valued at approximately $54,000. 5.19% of the stock is currently owned by institutional investors and hedge funds.

Senestech Company Profile

(Get Free Report)

SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.

The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.

Featured Stories

Receive News & Ratings for Senestech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senestech and related companies with MarketBeat.com's FREE daily email newsletter.